Therapies targeting Frizzled‐7/β‐catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model.

MLA

Bats, Marie‐Lise, et al. “Therapies Targeting Frizzled‐7/Β‐catenin Pathway Prevent the Development of Pathological Angiogenesis in an Ischemic Retinopathy Model.” FASEB Journal, vol. 34, no. 1, Jan. 2020, pp. 1288–303. EBSCOhost, https://doi.org/10.1096/fj.201901886R.

APA

Bats, M., Bougaran, P., Peghaire, C., Gueniot, F., Abelanet, A., Chan, H., Séguy, C., Jeanningros, S., Jaspard, V. B., Couffinhal, T., Duplàa, C., & Dufourcq, P. (2020). Therapies targeting Frizzled‐7/β‐catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model. FASEB Journal, 34(1), 1288–1303. https://doi.org/10.1096/fj.201901886R

Chicago

Bats, Marie‐Lise, Pauline Bougaran, Claire Peghaire, Florian Gueniot, Alice Abelanet, Hélène Chan, Camille Séguy, et al. 2020. “Therapies Targeting Frizzled‐7/Β‐catenin Pathway Prevent the Development of Pathological Angiogenesis in an Ischemic Retinopathy Model.” FASEB Journal 34 (1): 1288–1303. doi:10.1096/fj.201901886R.